Walnut Creek, Calif.-based John Muir Health is partnering with Ambience Healthcare, a healthcare artificial intelligence company, to integrate its generative AI scribe within its Epic EHR.
A year after the FDA found shredded quality documents at an Intas Pharmaceuticals drug manufacturing facility in India, Intas’ parent company Accord Healthcare resumed making cisplatin, which has been in dire shortage for months.
Grand Rapids, Mich.-based Corewell Health reported revenue of $11.2 billion in the first nine months of 2023, an 11.6% increase on the previous year’s period.
Danville, Pa.-based Geisinger Health, which is set to become the first health system incorporated into Kaiser Permanente’s Risant Health project, has reported an operating loss of $104.4 million for the nine-month period ending Sept. 30.
The nation’s second-largest pharmacy benefit manager, Express Scripts, is leaning into Mark Cuban Cost Plus Drugs’ business plan by selling drugs priced by their acquisition cost, pharmacy dispensing and service costs.